Evaluation of Pharmacokinetics and Safety of the Biosimilar (B01711) and Insulin Degludec/Insulin Aspart (IDegAsp, Ryzodeg) in Healthy Chinese Adults in a Randomized, Open-Label, Single-Dose, Crossover, Phase I Study

Liu H, Cao H, Li T, Chen X, Yu H, Sun J, Yu Y

Drug Design, Development and Therapy 2025, 19:2863-2871

Published Date: 11 April 2025